Alcon Pharma GmbH - Company Review
Alcon Pharma GmbH - Company ReviewSummary
Alcon Pharma GmbH (Alcon), a subsidiary of Novartis AG develops and produces innovative drugs and devices to meet the requirements of modern ophthalmology. The company offers ophthalmology products which include laser refractive cataract surgery, small incision management, intraocular accessories, surgical microscopes, surgical material, diagnosis and eye-tracking and retina products, among others. Its general eye care products comprise vision care contact lenses and care products. The company operates in Canada, Italy, Mexico, Portugal, Serbia, Slovenia, Spain, Austria, Belgium, Argentina, Brazil, France and the US, among others. Alcon is headquartered in Freiburg im Breisgau, Germany.
This comprehensive company report of Alcon Pharma GmbH provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.